Donostia International Physics Center, Paseo Manuel de Lardizabal 4, Donostia, 20018, Spain.
CIC biomaGUNE, Paseo de Miramón 182, Donostia, 20014, Spain.
Chemistry. 2019 May 10;25(27):6651-6660. doi: 10.1002/chem.201806341. Epub 2019 Feb 25.
Catalysis has strongly emerged in the field of medicinal inorganic chemistry as a suitable tool to deliver new drug candidates and to overcome drawbacks associated to metallodrugs. In this Concept article, we discuss representative examples of how catalysis has been applied in combination with metal complexes to deliver new therapy approaches. In particular, we explain key achievements in the design of catalytic metallodrugs that damage biomolecular targets and in the development of metal catalysis schemes for the activation of exogenous organic prodrugs. Moreover, we discuss our recent discoveries on the flavin-mediated bioorthogonal catalytic activation of metal-based prodrugs; a new catalysis strategy in which metal complexes are unconventionally employed as substrates rather than catalysts.
催化在药物无机化学领域已经崭露头角,成为提供新候选药物和克服金属药物相关缺点的合适工具。在这篇观点文章中,我们讨论了催化与金属配合物相结合应用于提供新治疗方法的代表性实例。特别地,我们解释了在设计破坏生物分子靶标的催化金属药物和开发用于激活外源性有机前药的金属催化方案方面的关键成就。此外,我们还讨论了我们最近在黄素介导的生物正交催化金属基前药的发现;这是一种新的催化策略,其中金属配合物被非常规地用作底物而不是催化剂。